Diligence memo · auto-generated · as of July 2, 2026
Upstream Biotechnology, Inc.
Upstream Biotechnology, Inc. has raised $625K over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Upstream Biotechnology, Inc. operates in Biotech, based in DURHAM.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Upstream Biotechnology, Inc. has raised $625K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $625K on 2025-08-26.
Most recent recorded round closed around 2025-08-26.
Valuation (modeled)modeled
Provath models Upstream Biotechnology, Inc. at approximately $1.4M (range $333K–$3.3M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 10 mo ago; this sector typically re-raises about every 11 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 72% of Biotech peers (233 compared).
Modeled value ranks above 69% of those peers.
Closest niche peers: Epoch Biotech, LLC, Corami Biotech Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.